U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Implementation of Signal Detection Capabilities in the Sentinel System - 12/03/2018
  1. News & Events for Human Drugs

Meeting | In Person

Event Title
Implementation of Signal Detection Capabilities in the Sentinel System
December 3, 2018

Date:
December 3, 2018

Date:

December 3, 2018

Location:

Hyatt Regency Bethesda
1 Bethesda Metro Center
Bethesda, MD 20814

Time:

9:00 am to 4:30 pm

BACKGROUND:

On December 3, 2018, in cooperative agreement with the U.S. Food and Drug Administration (FDA), the Robert J. Margolis, MD, Center for Health Policy at Duke University will convene a public workshop to explore opportunities to implement signal detection capabilities in the Sentinel System. Authorized in 2007 by the Food and Drug Administration Amendments Act (FDAAA), the Sentinel System is an active and fully functioning postmarket safety surveillance system that can rapidly scale distributed analyses on data collected by a diverse range of Sentinel Data Partners to identify potential safety risks related to the use of prescription drugs. To continue advancing and modernizing this data infrastructure, the Agency is seeking broad stakeholder input on the landscape of methodological approaches for signal detection, as well as the opportunities and challenges to implement these approaches in Sentinel’s distributed data network. Discussion will also consider key governance and operational needs for implementing signal detection tools in a hypothesis free environment. Stakeholder input received at this workshop will further inform the Agency’s thinking around these priority issues and support strategic planning in the Sentinel System.

A meeting agenda will be posted in advance of the workshop. The webcast for this event will be found on this page and will go live once the event begins.

Funding for this conference was made possible by a cooperative agreement from the Food and Drug Administration, Center for Drug Evaluation Research. The views expressed in written conference materials and the speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsements by the U.S. Government.

Registration:

Visit Implementation of Signal Detection Capabilities registration page for more information and to register.

 

Back to Top